In 2019, Son et al. demonstrated that irradiation (3 Gy) combined with HT (44 °C, 60 min) inhibited the progression of lung cancer via elevated NR4A3 and KLF11 expression, which is critical for enhancing the effectiveness of combined treatment [65]. This evidence concerns the gene NR4A3 and lung cancer.